Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 63629-8474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 63629-8474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)
Not available.*
FDA Label Image

Label (Lbl636298474)

Label (Lbl636298474)
This is a medication label for NILD, which contains 150 mg bupropion HCL, USP, and is an extended-release tablet. It is important to keep this medication out of reach of children and store at 25°C - 30°C. It should be dispensed in tight, light-resistant containers in compliance with USP with child-resistant closures. It is important to not use NILD in combination with ZYBAN® or any other medication that contains bupropion hydrochloride. The NDC for this medication is 63629-8474-1 and it comes in a package of 30 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.